In a information launch on October 9, Bain & Firm and KLAS Analysis revealed the outcomes of a examine that discovered that US healthcare suppliers and payers are growing their Synthetic Intelligence (AI) investments primarily to spice up revenue margins, specializing in utilizing know-how to enhance returns.
The deal with know-how options that maximize earnings is growing because the healthcare sector’s use of AI shifts from broad exploration to focused implementation for monetary good points, in accordance with the Bain and KLAS’s 2025 Healthcare IT Spending examine.
The examine confirmed that 70 p.c of suppliers and 80 p.c of payers now have an AI technique both in place or in improvement, up from 60 p.c for each teams in final yr’s Bain/KLAS survey.
Moreover, the examine discovered that income cycle administration (RCM) and scientific workflow are key priorities for suppliers, whereas payers deal with utilization and community administration. Suppliers stay capacity-constrained and prioritize options with a transparent return on funding (ROI), in accordance with the press announcement. Payers take care of increased medical loss ratios, elevated utilization charges, and higher risk-adjustment scrutiny as they put together for enrollment pressures.
“Executives need shortly scalable options that deal with key enterprise challenges and pay for themselves with tangible outcomes and quick time-to-value home windows,” mentioned Aaron Feinberg, associate in Bain & Firm’s Healthcare & Life Sciences and Personal Fairness apply, in a press release. “That is all in regards to the backside line now.”
“AI in healthcare is right here to remain, and suppliers and payers are properly transferring from exploration to execution,” mentioned Adam Gale, CEO of KLAS Analysis, in a press release.
Bain/KLAS surveyed some 228 US healthcare suppliers and payer executives for this examine.
